TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY

被引：20
|
作者：
Manns, M. [1 ]
Muir, A. [2 ]
Adda, N. [3 ]
Jacobson, I. [4 ]
Afdhal, N. [5 ]
Heathcote, J. [6 ]
Zeuzem, S. [7 ]
Reesink, H. [8 ]
Terrault, N. [9 ]
Bsharat, M. [3 ]
George, S. [3 ]
McHutchison, J. [2 ]
Di Bisceglie, A. [10 ]
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
[3] Vertex Pharmaceut, Cambridge, MA USA
[4] Weill Cornell Med Coll, New York, NY USA
[5] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[6] Univ Toronto, Toronto, ON, Canada
[7] Univ Frankfurt, Frankfurt, Germany
[8] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[9] Univ Calif San Francisco, San Francisco, CA 94143 USA
[10] St Louis Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)61046-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1044
引用
收藏
页码：S379 / S379
页数：1
相关论文
共 50 条
  • [21] HCV core Ag as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alfa-2b plus ribavirin
    Buti, M
    Valdes, A
    Mendez, C
    Schaper, M
    Sauleda, S
    Rodriguez-Frias, F
    Jardi, R
    Esteban, R
    Guardia, J
    JOURNAL OF HEPATOLOGY, 2004, 40 : 138 - 138
  • [22] Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaiVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study
    Moog, Gero
    Mauss, Stefan
    Hueppe, Dietrich
    Spengler, Ulrich
    Schott, Eckart
    Eisenbach, Christoph
    Schober, Andreas
    Heyne, Renate
    Jung, Maria-Christina
    Teuber, Gerlinde
    Doss, Margareta Frank
    Roessle, Martin
    Pape, Stefan
    Schuchmann, Marcus
    Alshuth, Ulrich
    Buggisch, Peter
    GASTROENTEROLOGY, 2013, 144 (05) : S983 - S983
  • [23] A study of telaprevir (TVR) with peginterferon alfa-2a (P) and ribavirin (R) in subjects with well-documented prior P/R null response, non-response or relapse: Preliminary results
    Poordad, F.
    Shiffman, M.
    Sherman, K.
    Smith, J.
    Yao, M.
    George, S.
    Adda, N.
    McHutchison, J.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S374 - S375
  • [24] TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA 2B AND RIBAVIRIN THERAPY FOR GENOTYPE 1 CHRONIC HCV PATIENTS: PHASE 3 STUDY IN JAPAN
    Okanoue, Takeshi
    Hayashi, Norio
    Tsubouchi, Hirohito
    Chayama, Kazuaki
    Toyota, Joji
    Kumada, Hiromitsu
    HEPATOLOGY, 2011, 54 : 985A - 986A
  • [25] REALIZE TRIAL FINAL RESULTS: TELAPREVIR-BASED REGIMEN FOR GENOTYPE 1 HEPATITIS C VIRUS INFECTION IN PATIENTS WITH PRIOR NULL RESPONSE, PARTIAL RESPONSE OR RELAPSE TO PEGINTERFERON/RIBAVIRIN
    Zeuzem, S.
    Andreone, P.
    Pol, S.
    Lawitz, E. J.
    Diago, M.
    Roberts, S.
    Focaccia, R.
    Younossi, Z. M.
    Foster, G. R.
    Horban, A.
    Pockros, P. J.
    Van Heeswijk, R.
    de Meyer, S.
    Luo, D.
    Picchio, G.
    Beumont, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S3 - S3
  • [26] Prove1: Results from a phase 2 study of telaprevir with peginterferon alfa-2a and ribavirin in treatment-naive subjects with hepatitis C
    Everson, Gregory T.
    Jacobson, Ira M.
    Gordon, Stuart C.
    McHutchison, John G.
    Kaufman, Robert
    McNair, Lindsay
    Muir, Andrew
    GASTROENTEROLOGY, 2008, 134 (04) : A758 - A758
  • [27] PATIENT REPORTED OUTCOMES AMONG CHRONIC HEPATITIS C PATIENTS RETREATED WITH PEGINTERFERON ALFA-2A/RIBAVIRIN AFTER NON-RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRIN IN SPAIN
    Olveira, A.
    Rincon, D.
    Diago, M.
    Crespo, J.
    Calleja, J. L.
    Salmeron, J.
    Andrade, R.
    Romero, M.
    VALUE IN HEALTH, 2011, 14 (07) : A282 - A282
  • [28] Liver transplant center focused experience with peginterferon alfa-2a, ribavirin and telaprevir therapy in patients with genotype 1 hepatitis C cirrhosis
    Gallegos-Orozco, Juan F.
    Chervenak, Amy E.
    Carey, Elizabeth J.
    Aqel, Bashar
    Byrne, Thomas J.
    Hartel, Lorrie A.
    Rakela, Jorge
    Vargas, Hugo E.
    HEPATOLOGY, 2012, 56 : 218A - 219A
  • [29] A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C
    Flisiak, Robert
    Shiffman, Mitchell
    Arenas, Juan
    Cheinquer, Hugo
    Nikitin, Igor
    Dong, Yuping
    Rena, Khurram
    Srinivasan, Subasree
    PLOS ONE, 2016, 11 (10):
  • [30] Peginterferon alfa-2a and peginterferon alfa-2b combined with ribavirin in patients with genotype 1 chronic hepatitis C: Results of a prospective single-centre study
    Berak, Hanna
    Laskus, Tomasz
    Kolakowska-Rzadzka, Anna
    Wasilewski, Marek
    Stanczak, Janusz J.
    Bardadin, Krzysztof
    Walewska-Zielecka, Bozena
    Horban, Andrzej
    ADVANCES IN MEDICAL SCIENCES, 2014, 59 (02): : 261 - 265
12345